In vitro drug susceptibility of Acanthamoeba castellani to chloroquine, ivermectin and fungizon

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 27, Issue 2, 1996, Pages 319-324

  Noor Rain, A ^a   Radzan, T ^a   Sajiri, S ^a   Mak, J W ^a  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIAMEBIC AGENT; ANTIINFECTIVE AGENT; CHLOROQUINE; IVERMECTIN;

ACANTHAMOEBA; ANIMAL; ARTICLE; CLASSIFICATION; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; GROWTH, DEVELOPMENT AND AGING; TIME;

ACANTHAMOEBA; AMEBICIDES; AMPHOTERICIN B; ANIMALS; ANTI-BACTERIAL AGENTS; CHLOROQUINE; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE; IVERMECTIN; TIME FACTORS;

EID: 0030154238     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Anderson K, Jamienson A. Primary amoebic meningoencephalitis. Lancet 1972a; 1 : 902-3.
2. Carter RF, Cullity GJ, Ojeda VJ, Silberstein P, Willaert E. A fatal case of meningoencephalitis due to a free-living amoeba of uncertain identity probably Acanthamoeba sp. Pathology 1981; 13 : 51-68.
3. Cooke DW, Lallinger GJ, Durack DT. In vitro sensitivity of Naegleria fowleri to qinghaosu and dihydroqinghaosu. J Parasitol 1987; 73 : 411-3.
4. Culbertsoni CG, Holmes DH, Overton WM. Hartmannella castellanii (Acanthamoeba sp). Preliminary report on experimental chemotheraphy. Am J Clin Pathol 1965; 43 : 361-4.
5. Ferrante A. Comparative sensitivity of Naegleria fowleri to amphotericin B and amphotericin B methyl ester. Trans R Soc Trop Med Hyg 1982; 76 : 476-8.
6. Ferrante A, Rowan-Kelly B, Thong TH. In vitro sensitivity of virulent Acanthamoeba culbertsoni to a variety of drugs and antibiotics. Int J Parasitai 1984; 14 : 53-6.
7. Ginsbury H, Krungliak M. Biochem Pharmacol 1988; 37 : 2013-8.
8. Homewood CA, Warhurst DC, Peters W, Baggaley VC. Lysosome, pH and the anti-malarial action of chloroquine. Nature 1972; 235 : 50-2.
9. Kobayashi GS, Medoff G. Antifungal agents: Recent developments. Ann Rev Microbiol 1977; 31 : 291-308.
10. Meshnick SR. Chloroquine as intercalator: a hyphothesis revived. Parasitol Today 1990; 6 : 77-9.
11. Mehlotra RK, Shukla OP. In vitro susceptibility of Acanthamoeba culbertsoni to inhibitors of folate biosynthesis. J Eukaryote Microbiol 1993; 40 : 14-7.
12. Nagington J, Richard JE. Chemotherapeutic compounds and acanthamoeba from eye infections. J Clin Pathol 1976; 29 : 648-51.
13. Osato MS, Robinson NM, Wilhelmus KR, Jones B. In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba. Rev Infect Dis 1991; 13 (suppl 5) : S431-5.
14. Schmidt LH, Crosby R, Rasco J, Vaughan D. Antimalaria activities of various 4-quinolinemethanols with special attention to WR 142,490 (mefloqione). Antimicrob Agents Chemother 1978; 13 : 1011-30.
15. Wright P, Warhust D, Jones BR. Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 1985; 69 : 778-82.